Top Markets
Coin of the day
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Ранг среди акций #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Цена акции
$50.82
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$102.09M
Изменение (1 день)
1.90%
Изменение (1 год)
-
Страна
US
Торговля Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Категория

История дроблений акций Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
Акции Hemab Therapeutics Holdings, Inc. Common Stock (символ: COAG) прошли через 0 дроблений.
Последнее дробление произошло Aug 23, 2026.
Одна акция COAG, купленная до Aug 23, 2026, сейчас соответствует 0 акциям COAG.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH